These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10653835)

  • 1. Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy.
    Bartunek J; Weinberg EO; Tajima M; Rohrbach S; Katz SE; Douglas PS; Lorell BH
    Circulation; 2000 Feb; 101(4):423-9. PubMed ID: 10653835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
    Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
    J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats.
    Matsubara BB; Matsubara LS; Zornoff LA; Franco M; Janicki JS
    Basic Res Cardiol; 1998 Jun; 93(3):173-81. PubMed ID: 9689443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discoordinate re-expression of cardiac fetal genes in N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension.
    Zhang Y; Carreras D; de Bold AJ
    Cardiovasc Res; 2003 Jan; 57(1):158-67. PubMed ID: 12504825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
    Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I; Pechánová O; Pelouch V; Simko F
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
    Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
    Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
    Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA.
    Kobayashi N; Hara K; Watanabe S; Higashi T; Matsuoka H
    Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel diallyldisulfide analogs ameliorate cardiovascular remodeling in rats with L-NAME-induced hypertension.
    Sharma DK; Manral A; Saini V; Singh A; Srinivasan BP; Tiwari M
    Eur J Pharmacol; 2012 Sep; 691(1-3):198-208. PubMed ID: 22819707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O
    Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac-specific overexpression of metallothionein attenuates myocardial remodeling and contractile dysfunction in l-NAME-induced experimental hypertension: Role of autophagy regulation.
    Yang L; Gao JY; Ma J; Xu X; Wang Q; Xiong L; Yang J; Ren J
    Toxicol Lett; 2015 Sep; 237(2):121-32. PubMed ID: 26068063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
    Simko F; Potácová A; Pelouch V; Paulis L; Matúsková J; Krajcírovicová K; Pechánová O; Adamcová M
    Physiol Res; 2007; 56 Suppl 2():S55-S62. PubMed ID: 17824806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
    Rossi MA; Ramos SG; Prado CM
    J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats.
    Bourraindeloup M; Adamy C; Candiani G; Cailleret M; Bourin MC; Badoual T; Su JB; Adubeiro S; Roudot-Thoraval F; Dubois-Rande JL; Hittinger L; Pecker F
    Circulation; 2004 Oct; 110(14):2003-9. PubMed ID: 15451797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone.
    Coelho-Filho OR; Shah RV; Neilan TG; Mitchell R; Moreno H; Kwong R; Jerosch-Herold M
    J Am Heart Assoc; 2014 Jun; 3(3):e000790. PubMed ID: 24965024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib aggravates cardiac apoptosis in L-NAME-induced pressure overload model in rats: Immunohistochemical determination of cardiac caspase-3, Mcl-1, Bax and Bcl-2.
    Mosaad SM; Zaitone SA; Ibrahim A; El-Baz AA; Abo-Elmatty DM; Moustafa YM
    Chem Biol Interact; 2017 Jun; 272():92-106. PubMed ID: 28526264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
    de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
    Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension.
    Pechánová O; Bernátová I; Babál P; Martínez MC; Kyselá S; Stvrtina S; Andriantsitohaina R
    J Hypertens; 2004 Aug; 22(8):1551-9. PubMed ID: 15257179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
    López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
    Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.